Benjamin L. Palleiko, CFO, Cbo: KalVista Pharmaceuticals KALV Sell · Filed 24/02/16

Trade details

Type: Insider sale
Amount: $613,233.55
Shares · price: 40,855 sh · $15.01 a share
Held after: 159,088 sh
Stock: KalVista Pharmaceuticals KALV
Person: Benjamin L. PalleikoCFO, Cbo
Trade date: 24/02/14
Filed: 24/02/16
Days to filing: 2 days

Sold 20.4% of holdings

Share of holding sold: 20.4%

KalVista Pharmaceuticals trades, last 26 weeks

What else happened in KalVista Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/15~24/03/15

Benjamin L. Palleiko's recent trades

Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
Benjamin L. PalleikoCEO
SellKalVista Pharmaceuticals
Sell
KalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09

Benjamin L. Palleiko, CFO — sold $613.2K of KalVista Pharmaceuticals KALV · 20.4% of holdings | Whalegun